Recently, our group has reported [17] in a murine melanoma model that the antitumor efficacy of these vaccines can be partially recovered (approximately 50%) when the FOXP3 gene was silenced with antisense oligonucleotides before the vaccine administration. The gene discussed is FOXP3; the disease is melanoma.